Breaking News Instant updates and real-time market news.

FIT

Fitbit

$13.32

-0.1 (-0.75%)

, SSNLF

Samsung

12:32
10/13/16
10/13
12:32
10/13/16
12:32

Cleveland Clinic: Study says wrist heart monitors less accurate than chest-worn

According to a research letter published in the JAMA Cardiology journal, wrist-worn fitness trackers are not as accurate as chest-worn heart monitors, Cleveland Clinic says. Cleveland Clinic said that, according to the study, chest-worn monitors work in a similar way to an EKG, which physicians use for diagnostic purposes, while wrist-worn monitors use optical sensors to detect blood coursing through veins, which has some recognized drawbacks. Wrist trackers read blood flow when it's farther from your heart, and accuracy also can be reduced by light hitting the sensor as you move your arm or flex your wrist, according to Cleveland Clinic. While Dr. Gillinov of the study said that wrist-worn monitors are fine for recreational use and are more accurate at measuring resting heart rates, they are less accurate when used during exercise. Companies that make fitness trackers include Fitbit (FIT), Samsung (SSNLF), and Garmin (GRMN). Reference Link

FIT

Fitbit

$13.32

-0.1 (-0.75%)

SSNLF

Samsung

GRMN

Garmin

$48.25

0.19 (0.40%)

  • 23

    Oct

  • 26

    Oct

  • 02

    Nov

  • 14

    Nov

  • 08

    Dec

FIT Fitbit
$13.32

-0.1 (-0.75%)

09/29/16
09/29/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Coca-Cola (KO) downgraded to Hold from Buy at Stifel with analyst Mark Swartzberg saying that Coca-Cola's and Pepsi's organic EPS growth appears to be similar, but he believes that Pepsi is less vulnerable to foreign exchange fluctuations. 2. Fitbit (FIT) downgraded to Underweight from Sector Weight at Pacific Crest analyst Brad Erickson citing his channel checks which indicated that Charge 2, the company's flagship holiday product, is off to a slow start. 3. Discovery (DISCA) downgraded to Market Perform from Outperform at Barrington with analyst James Goss saying that Brexit and sports costs are dragging on its international results and foreign exchange tailwinds are moderating in many geographies. 4. Sonus (SONS) downgraded to Underperform from Market Perform at Cowen with analyst Paul Silverstein saying the firm's industry checks uncovered operational challenges and ongoing employee and executive churn. 5. Alcobra (ADHD) downgraded to Hold from Buy at Cantor and to Perform from Outperform at Oppenheimer. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/29/16
MZHO
09/29/16
NO CHANGE
MZHO
Fitbit Charge 2 checks remain strong, pullback unwarranted, says Mizuho
Mizuho's checks indicate Fitbit's Charge 2 sell through remains strong with favorable reviews, despite investor concerns. The firm's analyst views the pullback in Fitbit shares as unwarranted, especially since Q3 guidance assume minimal unit sales, and expects the Charge 2 to compete well and serve as a catalyst for Holiday season into Spring 2017. Mizuho continues to believe in Fitbit's long-term opportunity to maintain dominant share with in the increasingly growing global market for wearables while pursing opportunities in the healthcare industry.
10/07/16
CLVD
10/07/16
NO CHANGE
CLVD
Cleveland Research is cautious on Fitbit heading into Q4 and Q1 2027
Cleveland Research is cautious on Fitbit heading into Q4 and Q1 2027 saying new product uptake is muted and is concerned about inventory levels.
09/29/16
MZHO
09/29/16
NO CHANGE
MZHO
Fitbit shares defended at Mizuho
SSNLF Samsung

08/01/16
NEED
08/01/16
NO CHANGE
Target $65
NEED
Buy
Synaptics price target lowered to $65 from $88 at Needham
Needham analyst Rajvindra Gill lowered his price target for Synaptics (SYNA) to $65 from $88 on a lower earnings multiple as he remains uncertain on whether the company has secured the OLED DDIC for Apple's (AAPL) iPhone 8 versus an internal Samsung (SSNLF) solution. The analyst reiterates a Buy rating on Synaptics' shares, saying the company will remain one of the leaders in the display markets.
10/12/16
WELS
10/12/16
NO CHANGE
WELS
Market Perform
Wells doesn't see Apple as biggest beneficiary from Samsung issues
Wells Fargo analyst Maynard Um attributes the recent rally in shares of Apple (AAPL), at least in part, to Samsung's (SSNLF) issues with its Note 7 phones. Apple gained an incremental $14B in market capitalization at its intraday peak, which the analyst believes embeds more than 3M of incremental iPhone 7 Plus units. Samsung's production halt will help Apple, but other Android vendors with 5.7 inch phones could see a bigger benefit if Android users prefer to stick with Android, Um tells investors in a research note. He points out that LG, Kyocera, and Microsoft (MFST) have 5.7 inch Android phones at U.S. carriers. Um thinks expectations for Apple into earnings "have risen materially." He keeps a Market Perform rating on the iPhone maker. Apple closed yesterday up 25c to $116.30.
10/11/16
DRXL
10/11/16
NO CHANGE
Target $185
DRXL
Buy
Apple could gain 8M iPhone units from Note 7 troubles, says Drexel Hamilton
Drexel Hamilton analyst Brian White estimates Apple (AAPL) has an opportunity to pick up "at least" 8 million incremental iPhone units in calendar year 2016 due to the Galaxy Note 7 being scrapped, noting that original market expectations were for Samsung (SSNLF) to ship about 10M-14M Galaxy Note 7 units in the second half of this year. The "fiasco" could permanently damage Samsung's smartphone brand, resulting in Apple market share gains, White added. The analyst keeps a Buy rating and $185 price target on Apple shares.
10/12/16
RHCO
10/12/16
NO CHANGE
RHCO
Best Buy, GameStop should be able to sidestep Note 7 impact, says SunTrust
SunTrust analyst David Magee, in two separate notes to investors, said that he believes Samsung's (SSNLF) troubles with the Galaxy Note 7 should not translate to shortfalls for either GameStop's (GME) mobile stores or for Best Buy (BBY), as in both cases most of their customers will simply pick different models. Sony's VR headset and other upcoming products in the category are "ideal for customers to try out in stores," added Magee, who keeps a Buy rating on both GameStop and Best Buy.
GRMN Garmin
$48.25

0.19 (0.40%)

09/08/16
BERN
09/08/16
NO CHANGE
BERN
Impact of Apple Watch likely to be 'limited' in near-term, says Bernstein
After Apple (AAPL) announced changes to its Apple Watch, Bernstein analyst A.M. Sacconaghi, Jr. says that the device's "relatively high price, continued tepid battery life and the absence of unique health monitoring capabilities will likely limit its overall impact near-term." Fitbit (FIT) and Garmin (GRMN) market watches that compete with Apple Watch. The analyst keeps a $125 price target and Outperform rating on Apple.
08/30/16
GSCO
08/30/16
NO CHANGE
GSCO
Sell
Garmin's Fitness/Outdoor sales to decelerate, says Goldman
Goldman analyst Simona Jankowski expects Garmin's (GRMN) Fitness/Outdoor sales to decelerate in 2H 2016/2017, leading to share underperformance, following Fitbit's new product launches. The analyst notes increasing direct competition in wearables and share of wallet competition from new consumer categories such as VR headsets, cameras and drones for the holidays, and reiterates his Sell rating on Garmin.
08/24/16
08/24/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Garmin (GRMN) downgraded to Sell from Neutral at Goldman with analyst Simona Jankowski citing valuation and near peak multiple. 2. Express (EXPR) downgraded to Hold from Buy at Deutsche Bank. 3. New Media (NEWM) downgraded to Sell from Neutral at Citi with analyst Jason Bazinet saying New Media bulls see $1B of M&A by year end, further synergies, organic revenues stabilizing in the fourth quarter of 2017, and a robust, sustainable dividend. However, Bazinet believes the bear case is more likely with no additional M&A, top-line trends that fall short of stable revenues by Q4 of 2017, and growing investor anxiety about the sustainability of the dividend. 4. Nordson (NDSN) downgraded to Perform from Outperform at Oppenheimer with analyst Christopher Glynn citing valuation. 5. Westfield Financial (WFD) downgraded to Underperform from Neutral at Macquarie citing disappointing first half 2016 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/24/16
GSCO
08/24/16
DOWNGRADE
Target $46
GSCO
Sell
Garmin downgraded to Sell from Neutral at Goldman
Goldman analyst Simona Jankowski downgraded Garmin to Sell citing valuation and near peak multiple. The analyst expects the key Fitness/Outdoor segment growth to slow in Q2 to 7% in 2017 from 29% in Q2 2016 resulting in share underperformance. Jankowski sees several negative catalysts over the next few months that include increased competitor product launches, increased competition from new emerging consumer electronics categories, and difficult comps.

TODAY'S FREE FLY STORIES

08:40
06/29/17
06/29
08:40
06/29/17
08:40
General news
U.S. initial jobless claims rose 2k to 244k in the week ended June 24 »

U.S. initial jobless…

AMRN

Amarin

$3.78

0.29 (8.31%)

08:39
06/29/17
06/29
08:39
06/29/17
08:39
Recommendations
Amarin analyst commentary  »

Jefferies boosts Amarin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$32.81

0.65 (2.02%)

08:39
06/29/17
06/29
08:39
06/29/17
08:39
Hot Stocks
Celltrion, Teva announce FDA acceptance of BLA for Rituxan biosimilar »

Celltrion and Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

IMNP

Immune Pharmaceuticals

$2.97

0.15 (5.32%)

08:38
06/29/17
06/29
08:38
06/29/17
08:38
Hot Stocks
Immune Pharmaceuticals reaches agreement on Pint Pharma transaction »

Immune…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKBA

Akebia

$15.50

-0.19 (-1.21%)

08:38
06/29/17
06/29
08:38
06/29/17
08:38
Technical Analysis
Technical View: Akebia falls on 4M share Spot Secondary »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

PIR

Pier 1 Imports

$5.38

0.04 (0.75%)

08:38
06/29/17
06/29
08:38
06/29/17
08:38
Downgrade
Pier 1 Imports rating change  »

Pier 1 Imports downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTLS

Chart Industries

$33.15

0.91 (2.82%)

08:37
06/29/17
06/29
08:37
06/29/17
08:37
Upgrade
Chart Industries rating change  »

Chart Industries upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Wal-Mart

$76.51

0.5 (0.66%)

, AMZN

Amazon.com

$990.33

13.55 (1.39%)

08:37
06/29/17
06/29
08:37
06/29/17
08:37
Periodicals
Walmart sending 'veiled' threats to truckers amid war with Amazon, NY Post says »

Walmart (WMT) is sending…

WMT

Wal-Mart

$76.51

0.5 (0.66%)

AMZN

Amazon.com

$990.33

13.55 (1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNI

Silver Spring

$11.28

0.1 (0.89%)

08:36
06/29/17
06/29
08:36
06/29/17
08:36
Hot Stocks
Silver Spring selected for Grant PUD advanced metering program »

Silver Spring Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPNC

Spectranetics

$38.35

7.95 (26.15%)

08:36
06/29/17
06/29
08:36
06/29/17
08:36
Downgrade
Spectranetics rating change  »

Spectranetics downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARNA

Arena Pharmaceuticals

$16.53

1.3 (8.54%)

08:35
06/29/17
06/29
08:35
06/29/17
08:35
Hot Stocks
Arena Pharmaceuticals completes ralinepag Phase 1 trial »

Arena Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

CCJ

Cameco

$9.53

0.1056 (1.12%)

08:35
06/29/17
06/29
08:35
06/29/17
08:35
Initiation
Cameco initiated  »

Cameco initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUBN

Commerce Union Bancshares

$26.04

1.54 (6.29%)

08:34
06/29/17
06/29
08:34
06/29/17
08:34
Hot Stocks
Commerce Union Bancshares raises quarterly dividend 9.1% to 6c per share »

Commerce Union Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

PFE

Pfizer

$33.75

-0.02 (-0.06%)

08:33
06/29/17
06/29
08:33
06/29/17
08:33
Hot Stocks
Pfizer to evaluate Alcyone's Pulsar technology to develop genetic therapy method »

Pfizer has entered into a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

  • 02

    Aug

  • 27

    Aug

08:32
06/29/17
06/29
08:32
06/29/17
08:32
General news
Jobless Claims data reported »

Week of 6/24 Jobless…

08:32
06/29/17
06/29
08:32
06/29/17
08:32
General news
Real GDP data reported »

Real GDP up 1.4% vs.…

INPX

Inpixon

08:32
06/29/17
06/29
08:32
06/29/17
08:32
Syndicate
Inpixon raises $6M in a public offering of common stock and warrants »

Inpixon announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OA

Orbital ATK

$98.71

1.7 (1.75%)

08:32
06/29/17
06/29
08:32
06/29/17
08:32
Hot Stocks
Orbital ARK receives contract to repair trainer aircraft for Iraqi Air Force »

Orbital ATK has received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CST

CST Brands

, LBIO

Lion Biotechnologies

08:30
06/29/17
06/29
08:30
06/29/17
08:30
Options
One new option listing and two option delistings on June 29th »

New option listings for…

CST

CST Brands

LBIO

Lion Biotechnologies

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$154.30

0.58 (0.38%)

08:26
06/29/17
06/29
08:26
06/29/17
08:26
Recommendations
McDonald's analyst commentary  »

McDonald's price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$27.08

-0.13 (-0.48%)

08:22
06/29/17
06/29
08:22
06/29/17
08:22
Upgrade
General Electric rating change  »

General Electric upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

$DJT

DJ Transportation Average

08:21
06/29/17
06/29
08:21
06/29/17
08:21
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

08:20
06/29/17
06/29
08:20
06/29/17
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

08:20
06/29/17
06/29
08:20
06/29/17
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRN

Trinity Industries

$28.35

1.05 (3.85%)

08:20
06/29/17
06/29
08:20
06/29/17
08:20
Recommendations
Trinity Industries analyst commentary  »

Trinity Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.